Browse drugs

… high-dose corticosteroids, six sessions of plasmapheresis, and rituximab. Due to persistent pancytopenia with febrile neutropenia, empir…

…pecialist for monitoring/initiation of antiviral therapy before Rituximab treatment.The role of pharmacy technicians contributing to pati…

…SF-36).Conclusions These findings suggest that long-term use of rituximab provides sustained clinical benefit in patients with progressiv…

…for systemic sclerosis (SSc) treatment, which newly recommended mycophenolate mofetil (MMF), rituximab (RTX), and tocilizumab (TCZ) as options for sk…

…h high baseline serum IgA2 anti-dsDNA antibodies, compared with rituximab alone. This biomarker-enrichment trial was developed from the i…

…rs, range 1–12) were included and received a single low dose of rituximab. Among the nine patients treated, seven were acetylcholine rece…

…nsities and progressive sensory and motor decline, treated with rituximab. Case 2, also secondary to MS, displayed extensive cervical mye…

…se to methotrexate, he was subsequently shifted to intravitreal rituximab injections. He received monthly intravitreal injections of ritu…

…6% vs 51%, p=0.003), including after treatment discontinuation. Avacopan was associated with accelerated glucocorticoid tapering (≤5 mg/…

…nation treatment with mycophenolate and rituximab (MMF-RTX) vs. rituximab monotherapy (RTX) in a single-center cohort of patients affecte…

…uffy hands, telangiectasias, ANA positive. She was treated with methotrexate . Over the course of the disease she developed digital ulcers, …

…-CD20 therapy (768 on rituximab and 509 on ocrelizumab) and 677 natalizumab. Natalizumab significantly reduced ARR compared with anti-CD20 …